Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|March 12, 2022
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes StatusIlaria Cavallari, Giuseppe Patti, Ernesto Maddaloni, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary interventionFabio Mangiacapra, Emanuele Barbato, Giuseppe Patti, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Moderate mitral regurgitation: when to prefer clip over medical therapyFederica Coletti, Myriam Carpenito, Lorenzo Guarino, et al.
The American Journal of Cardiology|March 30, 2013
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study)Giuseppe Patti, Fabio Mangiacapra, Elisabetta Ricottini, et al.
Journal of Cardiovascular Pharmacology|July 26, 2022
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element?Annunziata Nusca, Francesco Piccirillo, Michele Mattia Viscusi, et al.
Giornale Italiano Di Cardiologia (2006)|December 7, 2018
[The hybrid strategy for complete myocardial revascularization in the frail elderly patient]Annunziata Nusca, Rocco A Montone, Alessandro Sticchi, et al.
Platelets|August 27, 2013
Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitusFabio Mangiacapra, Aaron Peace, Emanuele Barbato, et al.
The American Journal of Cardiology|January 9, 2016
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study)Elisabetta Ricottini, Rosalinda Madonna, Domenico Grieco, et al.
European Journal of Internal Medicine|February 18, 2020
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidenceElisabetta Ricottini, Antonio Nenna, Rosetta Melfi, et al.
The American Journal of Cardiology|August 21, 2010
Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary interventionFabio Mangiacapra, Giuseppe Patti, Aaron Peace, et al.
Pageof 6